Medical Design Technology

News

Subscribe to MDT Magazine News

China Sky One Medical's Chief Financial Officer's Health Issues to Restrict His Availability to Investors

July 16, 2010 5:34 pm | by Bio-Medicine.Org | Comments

HARBIN, China , July 16 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that...

TOPICS:

Jiangchuan Macrolide Facility Update

July 16, 2010 12:34 pm | by Bio-Medicine.Org | Comments

CHENGDU, China , July 16 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics provides progress update on its Jiangchuan macrolide...

TOPICS:

MR-Guided Focused Ultrasound Symposium Announces Sponsors

July 16, 2010 12:34 pm | by Bio-Medicine.Org | Comments

CHARLOTTESVILLE, Va. , July 16 /PRNewswire-USNewswire/ --The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near...

TOPICS:
Advertisement

Advair Diskus (fluticasone propionate and salmeterol inhalation powder): Stolen Product Warning

July 16, 2010 11:31 am | by U.S. Food & Drug Administration | Comments

Certain inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot be assured and they should not be used.

TOPICS:

Earnings Preview: UnitedHealth reports 2Q earnings

July 16, 2010 10:45 am | by The Associated Press | Comments

Managed care company UnitedHealth Group Inc. reports second-quarter results July 20 before the market opens.WHAT TO WATCH FOR: The Minnetonka, Minn., insurer started 2010 strong. It reported a 21 percent year-over-year profit jump in the first quarter and said it had trimmed the percentage of...

Adjusting Market Research Structures and Activities to Maximize Payer Access & Insights

July 16, 2010 9:35 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C. , July 16 /- As the managed markets sector has increased in importance, leading organizations have refocused their market research efforts on delivering actionable insights into the payer world. A market research function that's focused on managed markets should provide...

TOPICS:

Health Management names Levine senior VP

July 16, 2010 7:45 am | by The Associated Press | Comments

Hospital operator Health Management Associates Inc. said Friday it named Alan Levine as its new senior vice president of health development operations and government relations.The appointment is effective Aug. 9.Levine most recently served as Secretary of the Louisiana Department of Health and...

Warner Chilcott Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product

July 16, 2010 7:36 am | by Bio-Medicine.Org | Comments

ARDEE, Ireland , July 16 /- Warner Chilcott plc (Nasdaq: WCRX ) announced today that it has received a communication from the U.S. Food & Drug Administration (FDA) related to its next generation Actonel® product (risedronate sodium) delayed-release tablets extending the...

TOPICS:
Advertisement

Siemens Primed to Help Customers Achieve Newly-Defined Criteria for 'Meaningful Use' of an Electronic Health Record

July 16, 2010 7:36 am | by Bio-Medicine.Org | Comments

MALVERN, Pa. , July 16 /- Today, Siemens Healthcare announced that the newly-released Final Rule on 'Meaningful Use' of Electronic Health Records (EHRs) provides an important boost to its ongoing campaign to help healthcare providers realize quality and efficiency gains through the use of...

TOPICS:

Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest and Conversion Rate Adjustment

July 16, 2010 7:36 am | by Bio-Medicine.Org | Comments

SARASOTA, Fla. , July 16 /- Roper Industries, Inc. (NYSE: ROP ) announced today that its Senior Subordinated Convertible Notes due 2034 (CUSIP No. 776696AA4) (the "Notes") will accrue contingent interest for the period of July 16, 2010 to January 15, 2011 at an annual rate of 0.25% of the...

TOPICS:

GTC regains U.S. rights to ATryn blood clot therapeutic

July 16, 2010 7:35 am | by Mass High Tech: The Journal of New England Technology | Comments

GTC Biotherapeutics Inc., a developer of drug therapies derived from animal proteins, has regained U.S. commercialization rights to ATryn, a drug intended to prevent blood clots, from Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark.

TOPICS:

Amedisys defends company in shareholder letter

July 16, 2010 5:45 am | by The Associated Press | Comments

Amedisys Inc. has issued a letter to its shareholders defending its home health care practices that have fallen under federal investigation.In the 21-page letter, released after financial markets closed Thursday, Amedisys challenged questions raised by The Wall Street Journal, which examined...

Cardinal Health Completes Acquisition of Healthcare Solutions Holding

July 15, 2010 2:38 pm | by Bio-Medicine.Org | Comments

DUBLIN, Ohio , July 15 /- Cardinal Health today completed the previously announced acquisition of Healthcare Solutions Holding, LLC, expanding the company's presence in specialty pharmaceutical services. Healthcare Solutions Holding is the parent company of a number of subsidiaries...

TOPICS:

Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimer's Disease at International Conference on Alzheimer's Disease (ICAD)

July 15, 2010 2:38 pm | by Bio-Medicine.Org | Comments

- Treatment with Nypta(R) (Tideglusib) (NP-12) was tolerated and produced positive effects on Alzheimer's patients in four of the five efficacy variables examined in the trial. - In view of the promising results of this trial, Noscira is preparing the next Phase IIb trial on Alzheimer's...

TOPICS:

Dynatronics Launches E-Commerce Website

July 15, 2010 2:38 pm | by Bio-Medicine.Org | Comments

SALT LAKE CITY , July 15 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced the launch of its e-commerce website at dynatronics.com .  The new website offers thousands of products for clinics and medical practitioners, particularly targeting the physical medicine market. "The...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading